EdneyEB, GillRW. Evolution of senescence and specific longevity. Nature, 1968; 220:281–282.
2.
OlshanskySJ, HayflickL, CarnesBA. Position statement on human aging. J Gerontol A Biol Sci Med Sci, 2002; 57:B292–B297.
3.
de GreyADNJ. Do we have genes that exist to hasten aging? New data, new arguments, but the answer is still no. Curr Aging Sci, 2015; 8:24–33.
4.
BlagosklonnyMV. Aging and immortality: Quasi-programmed senescence and its pharmacologic inhibition. Cell Cycle, 2006; 5:2087–2102.
5.
WilliamsGC. Pleiotropy, natural selection, and the evolution of senescence. Evolution, 1957; 11:398–411.
6.
BlagosklonnyMV. DNA- and telomere-damage does not limit lifespan: Evidence from rapamycin. Aging (Albany NY), 2021; 13:3167–3175.
7.
BirkisdóttirMB, JaarsmaD, BrandtRMC, et al.Unlike dietary restriction, rapamycin fails to extend lifespan and reduce transcription stress in progeroid DNA repair-deficient mice. Aging Cell, 2021; 20:e13302.
8.
de GreyADNJ. Protagonistic pleiotropy: Why cancer may be the only pathogenic effect of accumulating nuclear mutations and epimutations in aging. Mech Ageing Dev, 2007; 128:456–459.
9.
WuJJ, LiuJ, ChenEB, et al.Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression. Cell Rep, 2013; 4:913–920.
10.
de GreyADNJ. Falsifying falsifications: The most critical task of theoreticians in biology. Med Hypotheses, 2004; 62:1012–1020.
